CaCO3-coated hollow mesoporous silica nanoparticles for pH-responsive fungicides release

Wang, Jiaxu; Zhang, Jinxie; Wang, Xiuping; Wang, Jingying; Chen, Lina; Cao, Jiahui; Cao, Wei; Liang, Siyu; Luan, Ping; Zheng, Ke; Ouyang, Xiao-Kun; Gao, Li; Ou, Xiaowen; Zhang, Fan; Ou, Meitong; Mei, Lin

doi:10.1016/j.cclet.2024.109697

Cited by 1 publication

(1 citation statement)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fe NPs have attracted considerable interest as possible targeted drug delivery vehicles for antifungal drugs [196]. Fe NPs have special physicochemical characteristics that make them a good option for enhancing antifungal therapy, such as their small size and large surface area [197].…”

Section: Fe Nps As Targeted Drug Delivery Systems For Antifungal Agentsmentioning

confidence: 99%

Advances in the Optimization of Fe Nanoparticles: Unlocking Antifungal Properties for Biomedical Applications

Sandhu,

Raza,

Alqurashi

et al. 2024

Pharmaceutics

View full text Add to dashboard Cite

In recent years, nanotechnology has achieved a remarkable status in shaping the future of biological applications, especially in combating fungal diseases. Owing to excellence in nanotechnology, iron nanoparticles (Fe NPs) have gained enormous attention in recent years. In this review, we have provided a comprehensive overview of Fe NPs covering key synthesis approaches and underlying working principles, the factors that influence their properties, essential characterization techniques, and the optimization of their antifungal potential. In addition, the diverse kinds of Fe NP delivery platforms that command highly effective release, with fewer toxic effects on patients, are of great significance in the medical field. The issues of biocompatibility, toxicity profiles, and applications of optimized Fe NPs in the field of biomedicine have also been described because these are the most significant factors determining their inclusion in clinical use. Besides this, the difficulties and regulations that exist in the transition from laboratory to experimental clinical studies (toxicity, specific standards, and safety concerns) of Fe NPs-based antifungal agents have been also summarized.

show abstract

Section: Fe Nps As Targeted Drug Delivery Systems For Antifungal Agentsmentioning

confidence: 99%

Advances in the Optimization of Fe Nanoparticles: Unlocking Antifungal Properties for Biomedical Applications

Sandhu,

Raza,

Alqurashi

et al. 2024

Pharmaceutics

View full text Add to dashboard Cite

show abstract

CaCO3-coated hollow mesoporous silica nanoparticles for pH-responsive fungicides release

Cited by 1 publication

References 22 publications

Advances in the Optimization of Fe Nanoparticles: Unlocking Antifungal Properties for Biomedical Applications

Advances in the Optimization of Fe Nanoparticles: Unlocking Antifungal Properties for Biomedical Applications

Contact Info

Product

Resources

About